Biolytx
Oklahoma City, US · 1 known investors
Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.
Founders & leadership
HA
Heloise Anne PereiraProfessor / Inventor
Investors · 1
Frequently asked questions
- What does Biolytx do?
- Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.
- Who are Biolytx's investors?
- Biolytx's investors include Crawley Ventures.
- Where is Biolytx headquartered?
- Biolytx is headquartered in Oklahoma City, US.